1-(.beta.-D-arabinofuranosyl)-5-propynyluracil for treatment of VZV infections
US5028596A · kind A · utility
3Cited by
3References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 14, 1987 |
| Grant date | Jul 2, 1991 |
| Priority date | — |
| Expiry date | Dec 14, 2007 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is a method for using 1-(.beta.-D-arabinofuranosyl)-5-propynyluracil or its salts as the active ingredient in pharmaceutical compositions in the treatment of varicella zoster viral infections whether expressed as chicken pox or shingles.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.